CURX vs FTNT · $8.9M cap vs P/E 56, rev $3.90B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Fortinet Inc (FTNT) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
CURX does not have a complete income-statement cache yet.
Latest reported FTNT revenue for 2026-06-30 was $3.90B. Net income was $1.14B. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
CURX currently screens at market cap $8.9M. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Not investment advice. Open the CURX and FTNT stock pages for the full models.
Not investment advice.